Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573163
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionAlaa SadaNot Yet RecruitingPhase 2
NCT07573163Not Yet Recruiting
Phase 2
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionAlaa Sada
NCT07573917
Improving Insulin Sensitivity in Patients With Type 2 Diabetes Via Repeated Cold-induced Shivering ThermogenesisMaastricht University Medical CenterRecruitingNot Applicable
NCT07573917Recruiting
Not Applicable
Improving Insulin Sensitivity in Patients With Type 2 Diabetes Via Repeated Cold...Maastricht University Med...
NCT07572747
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf CountriesKhalid F AlhabibNot Yet RecruitingPhase 3
NCT07572747Not Yet Recruiting
Phase 3
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countrie...Khalid F Alhabib
NCT07573293
BPTB Versus Hamstring Autografts in ACL Reconstruction Among Professional AthletesCairo UniversityCompletedNot Applicable
NCT07573293Completed
Not Applicable
BPTB Versus Hamstring Autografts in ACL Reconstruction Among Professional Athlet...Cairo University
NCT07573085
Internet-delivered Emotion Regulation Individual Therapy or Adolescents (IERITA) With Self-injury Within Child and Adolescent Mental Health ServicesKarolinska InstitutetNot Yet RecruitingNot Applicable
NCT07573085Not Yet Recruiting
Not Applicable
Internet-delivered Emotion Regulation Individual Therapy or Adolescents (IERITA)...Karolinska Institutet
NCT07573436
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)ADC Therapeutics S.A.Not Yet RecruitingPhase 1
NCT07573436Not Yet Recruiting
Phase 1
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post...ADC Therapeutics S.A.
NCT07573449
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male ParticipantsOtsuka Pharmaceutical Development & Commercialization, Inc.CompletedPhase 1
NCT07573449Completed
Phase 1
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Si...Otsuka Pharmaceutical Dev...
NCT07572019
Ultrasound Guided Erectror Spinae Block Versus Intracavitary During Medical ThoracoscopyKafrelsheikh UniversityNot Yet RecruitingPhase 2
NCT07572019Not Yet Recruiting
Phase 2
Ultrasound Guided Erectror Spinae Block Versus Intracavitary During Medical Thor...Kafrelsheikh University
NCT07573761
Evaluation of the Effectiveness of Odontogenic Grafts Obtained From Human Teeth on Bone FormationIstanbul Saglik Bilimleri UniversityEnrolling By Invitation
NCT07573761Enrolling By Invitation
—
Evaluation of the Effectiveness of Odontogenic Grafts Obtained From Human Teeth...Istanbul Saglik Bilimleri...
NCT07574424
Normative Values For Physical FitnessRiphah International UniversityEnrolling By Invitation
NCT07574424Enrolling By Invitation
—
Normative Values For Physical FitnessRiphah International Univ...
NCT07572981
Study of the Effectiveness of Clinical Hypnosis and Self-hypnosis in Relieving Hot Flashes in Menopausal WomenUniversity Hospital, ToulouseNot Yet RecruitingNot Applicable
NCT07572981Not Yet Recruiting
Not Applicable
Study of the Effectiveness of Clinical Hypnosis and Self-hypnosis in Relieving H...University Hospital, Toul...
NCT07573566
Abdominal Aortic Tourniquet Application for Non-Traumatic Out-of-Hospital Cardiac ArrestKlinikum Klagenfurt am WörtherseeNot Yet RecruitingNot Applicable
NCT07573566Not Yet Recruiting
Not Applicable
Abdominal Aortic Tourniquet Application for Non-Traumatic Out-of-Hospital Cardia...Klinikum Klagenfurt am Wö...
NCT07573943
ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus InfectionFirst Affiliated Hospital of Chongqing Medical UniversityRecruitingPhase 4
NCT07573943Recruiting
Phase 4
ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chron...First Affiliated Hospital...
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572383
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPhase 2
NCT07572383Recruiting
Phase 2
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibros...National Heart, Lung, and...
NCT07574190
A Mobile Web App Intervention to Promote Cervical Cancer ScreeningUniversity of South DakotaNot Yet RecruitingNot Applicable
NCT07574190Not Yet Recruiting
Not Applicable
A Mobile Web App Intervention to Promote Cervical Cancer ScreeningUniversity of South Dakot...
NCT07573371
Understanding and Tailored Treatment of Low Anterior Resection SyndromeAalborg University HospitalRecruiting
NCT07573371Recruiting
—
Understanding and Tailored Treatment of Low Anterior Resection SyndromeAalborg University Hospit...
NCT07572630
Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Task Demands and Spatial Attention (Expt 2.2)National Eye Institute (NEI)Enrolling By InvitationNot Applicable
NCT07572630Enrolling By Invitation
Not Applicable
Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Task D...National Eye Institute (N...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting4 (20%)
Enrolling by invitation3 (15%)
Completed2 (10%)
not_applicable9 (45%)
Phase 24 (20%)
Not Specified3 (15%)
Phase 12 (10%)
Phase 31 (5%)
Phase 41 (5%)